Canada authorized Moderna to begin Phase 1 clinical trials on August 4 for a vaccine targeting the Bundibugyo strain of Ebola. The trial will evaluate safety, dosage range, and side effects, with an agreement in place for domestic manufacturing. No cases of Ebola have been recorded in Canada, which closed its borders on July 20 to foreign nationals recently in the Democratic Republic of Congo.